Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The practical takeaway: AOD-9604 has a clean safety profile in trials but a failed Phase 2b efficacy endpoint
These injections are considered a medical treatment and should be administered under the guidance of a trained professional
The dosage and frequency of administration can vary greatly depending on the specific application and individual response
The clinical signal is strongest in the recovery space
US$ 24.31
US$ 23.47
US$ 25.92
US$ 22.33
US$ 23.49
US$ 21.44
US$ 28.46
US$ 25.14
US$ 28.76
US$ 29.78
